Literature DB >> 31427203

Renal cell carcinoma treatment after first-line combinations.

Camillo Porta1, Manuela Schmidinger2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31427203     DOI： 10.1016/S1470-2045(19)30510-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

Review 1.  A Comprehensive Review of Clinical Cardiotoxicity Incidence of FDA-Approved Small-Molecule Kinase Inhibitors.

Authors:  Ying Jin; Zhifei Xu; Hao Yan; Qiaojun He; Xiaochun Yang; Peihua Luo
Journal:  Front Pharmacol       Date:  2020-06-12       Impact factor: 5.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.